# 21 CFR Part 201, Subpart A—General Labeling Provisions

21 CFR Part 201, Subpart A—General Labeling Provisions, “General Labeling Provisions”, is a CFR division of [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1).

IRI: <https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter C—DRUGS: GENERAL](https://ontology.bommaritollc.com/id/01a0f094-b59c-71c5-9205-607bcccd7551) › [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-division 21 CFR Part 201, Subpart A](https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9ee759fb1688)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edb18674d38)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-d933-74f2-9a73-756df62f4b8d)
- `schema:isPartOf`: [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1)
- `schema:legislationIdentifier`: 21 CFR Part 201, Subpart A
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationType`: [CFR division](https://ontology.bommaritollc.com/vocab/leg/cfrDivision)
- `schema:name`: General Labeling Provisions
- `skos:prefLabel`: 21 CFR Part 201, Subpart A—General Labeling Provisions

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Parts (17; `schema:isPartOf`):
  - [21 CFR 201.1 Drugs; name and place of business of manufacturer, packer, or distributor.](https://ontology.bommaritollc.com/id/01a0f094-c323-7021-8d85-134f433a5c84)
  - [21 CFR 201.10 Drugs; statement of ingredients.](https://ontology.bommaritollc.com/id/01a0f094-c326-7487-a2a0-911621021396)
  - [21 CFR 201.15 Drugs; prominence of required label statements.](https://ontology.bommaritollc.com/id/01a0f094-c327-719a-8363-7aff6eb6ee14)
  - [21 CFR 201.16 Drugs; Spanish-language version of certain required statements.](https://ontology.bommaritollc.com/id/01a0f094-c328-76c5-ac8b-1808e078da8d)
  - [21 CFR 201.17 Drugs; location of expiration date.](https://ontology.bommaritollc.com/id/01a0f094-c328-76c5-ac8b-181652989b04)
  - [21 CFR 201.18 Drugs; significance of control numbers.](https://ontology.bommaritollc.com/id/01a0f094-c329-70b2-8453-1d9102ac5580)
  - [21 CFR 201.19 Drugs; use of term “infant”.](https://ontology.bommaritollc.com/id/01a0f094-c32a-7274-9fae-48a5a83b2ad3)
  - [21 CFR 201.2 Drugs and devices; National Drug Code numbers.](https://ontology.bommaritollc.com/id/01a0f094-c324-7622-ae93-174496364fe0)
  - [21 CFR 201.20 Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.](https://ontology.bommaritollc.com/id/01a0f094-c32b-7270-a983-14ae810a94d7)
  - [21 CFR 201.21 Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.](https://ontology.bommaritollc.com/id/01a0f094-c32b-7270-a983-14bc465c0561)
  - [21 CFR 201.22 Prescription drugs containing sulfites; required warning statements.](https://ontology.bommaritollc.com/id/01a0f094-c32c-7536-a2ee-a114534b6f82)
  - [21 CFR 201.23 Required pediatric studies.](https://ontology.bommaritollc.com/id/01a0f094-c32d-7253-9639-a4afb9bad539)
  - [21 CFR 201.24 Labeling for systemic antibacterial drug products.](https://ontology.bommaritollc.com/id/01a0f094-c32e-7605-b9a5-95ef0661c731)
  - [21 CFR 201.25 Bar code label requirements.](https://ontology.bommaritollc.com/id/01a0f094-c32e-7605-b9a5-95fd49ecd676)
  - [21 CFR 201.26 Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile.](https://ontology.bommaritollc.com/id/01a0f094-c32f-7401-978f-2abf7e863d6d)
  - [21 CFR 201.5 Drugs; adequate directions for use.](https://ontology.bommaritollc.com/id/01a0f094-c325-720a-baa0-68cbaddef910)
  - [21 CFR 201.6 Drugs; misleading statements.](https://ontology.bommaritollc.com/id/01a0f094-c326-7487-a2a0-9108ec193f97)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6)
Cite as: 21 CFR Part 201, Subpart A—General Labeling Provisions. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
